The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
October 21st 2024
Novo Nordisk will present more detailed data in 2025 and plans to file for an expanded label for Rybelsus for this population.
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Is Hormone Therapy Dangerous for Women with Existing Heart Risk?
Researchers from the University of Michigan School of Public Health reported last month in the Archives of Internal Medicine that hormone therapy may produce adverse heart health effects even in women who begin treatment within the recommended timeframe post-menopause.
Antimalarial Treatment Prevents Diabetes in Arthritis Patients
November 26th 2008While obesity, hypertension, and diabetes have always shared connections, every now and then, scientists manage to make some of the unlikeliest connections. As it turns out, Geisinger Health System researchers found that "antimalarial medication may prevent the onset of diabetes in patients with rheumatoid arthritis."
Trimming Fast Food Advertising would Cut Back Child Obesity, Study Says
According to a new study published in the November issue of the Journal of Law and Economics, childhood obesity could be reduced by up to 18% by banning fast food advertisements in the United States.